-
Endocyte Announces $175.0 Million Proposed Public Offering of Common Stock
-
Pre-Open Movers 03/09: (PDLI) (ACRX) (ECYT) Higher; (AUTO) (VNRX) (BIG) Lower (more...)
-
Endocyte to Present at Upcoming Conferences
-
Pre-Open Stock Movers 01/21: (ZFGN) (XLNX) (FEYE) Higher; (OGXI) (ALKS) (SLM) Lower (more...)
-
Endocyte to Present at Upcoming Conferences
-
Notable Analyst Rating Changes 9/30: (AA) (FBC) (SSE) Upgraded; (TIBX) (ECYT) (ARMH) Downgraded
-
Pre-Open Stock Movers 9/9: (BNNY) (IPAS) (THLD) Higher; (FCEL) (FRAN) (PBY) Lower (more...)
-
Notable Analyst Rating Changes 05/02: (LNKD) (ARUN) (ENDP) Upgraded; (PEG) (ECYT) (WSH) Downgraded
-
Endocyte (ECYT) Closes 5.18M Offering; Sees Net Proceeds of $101.8M
-
Endocyte, Inc. Closes Public Offering of Common Stock
-
Endocyte (ECYT) Prices 4.5M Share Offering at $21
-
Endocyte, Inc. Prices Public Offering of Common Stock
-
Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)
-
Endocyte to Present at Upcoming Conferences
-
RBC Capital Starts Endocyte (ECYT) at Outperform
-
Endocyte (ECYT) Prices IPO at $6

